Trial intelligence / Profile preview

Magic Shave Powder Gold for Pseudofolliculitis Barbae

NCT04220502Phase 1Withdrawn

Sponsor
Wayne State University
Start
Aug 2020
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of magic shaving powder gold in pseudofolliculitis barbae (PFB) (2 arms), sponsored by Wayne State University. Primary endpoint: Investigator Global Assessment at 12 weeks. Planned start Aug 2020; status: withdrawn.

02

Drugs

magic shaving powder gold
03

Conditions

pseudofolliculitis barbae (PFB)

Beyond the preview

Go deeper on NCT04220502.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04220502.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call